Skip to main content
BXC
NYSE Trade & Services

BlueLinx 10-Q: Q3 Net Loss of $0.6M Despite 21% Gross Profit Jump

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
7
Price
$72.56
Mkt Cap
$570.337M
52W Low
$44.78
52W High
$93.8
52W Position info
62% above low
Off High info
23% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

BXC sits 62% above its 52-week low of $44.78 on elevated volume (1.9× avg).

Summary

BlueLinx's Q3 2026 10-Q shows sales up 8.5% to $812.6 million and gross margin up 170 basis points to 16.1%, but SG&A growth and a 126.6% tax rate pushed the quarter to a $0.6 million net loss.


Key Events · Earnings and Guidance · BXC

  • Q3 Swings to Net Loss

    Net loss of $0.6 million, or $0.07 per share, versus net income of $1.7 million ($0.20) in Q3 2025, despite sales rising 8.5% to $812.6 million.

  • Gross Margin Expands 170 bps

    Gross profit rose 21.0% to $131.0 million and gross margin reached 16.1% from 14.4%, helped by Disdero and specialty-product pricing.

  • One-Off Inventory and Duty Items

    Cost of products sold carried a $2.9 million unusual provision for discontinued inventory from a brand/vendor change, partly offset by a $2.2 million AD/CV duty benefit.

  • Costs and Tax Rate Bite

    SG&A rose 18.6% to $105.9 million and the effective tax rate hit 126.6%, turning $2.3 million of pre-tax income into a net loss.


Analysis · BXC · Trade & Services

The headline is a $0.6 million net loss, but the underlying story is margin mix and cost pressure, not liquidity. Sales rose 8.5% to $812.6 million and gross profit climbed 21.0% to $131.0 million, yet SG&A grew 18.6% and a 126.6% effective tax rate consumed the thin pre-tax profit. Two one-off items cut both ways: a $2.9 million write-down on discontinued inventory from a brand/vendor switch, partly offset by a $2.2 million antidumping-duty benefit. The balance sheet offers reassurance — $349.8 million of cash, no revolver borrowings and $339.1 million of availability.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BXC was trading at $72.56 on NYSE in the Trade & Services sector, with a market capitalization of approximately $570.3M. The 52-week trading range was $44.78 to $93.80. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BXC - Latest Insights

BXC
Nov 03, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $72.56
Real-time Price: $57.50 info
Change: -$15.06 (-21%) info
Market Cap: $449.144M info
BXC
Aug 04, 2026, 4:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $68.47
Real-time Price: $57.50 info
Change: -$10.97 (-16%) info
Market Cap: $449.144M info
BXC
Aug 04, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $69.00
Real-time Price: $57.50 info
Change: -$11.50 (-17%) info
Market Cap: $449.144M info
BXC
Aug 04, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $69.00
Real-time Price: $57.50 info
Change: -$11.50 (-17%) info
Market Cap: $449.144M info
BXC
May 19, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $46.86
Real-time Price: $57.50 info
Change: +$10.64 (+23%) info
Market Cap: $449.144M info